Business Solutions is the team of experts at Disneyland Paris, dedicated to organizing large venue events for companies, conferences, and congresses. Disneyland Paris is a unique venue and now the largest all-in-one destination for business tourism in Europe. With its own rail terminal, state-of-the-art congress centers, hotels, restaurants and a huge range of activities on offer, Disneyland Paris offers everything a company may need to make an event an outstanding success! With a staff of 150, Disney Business Solutions has a team of specialists ready to customize any type of event in the various Disneyland Paris venues available for events, including plenary rooms or exhibition areas. With a series of hotels and restaurants nearby, all event attendees are in a close, easily navigable site, also in proximity to the amenities of Disneyland Paris’ two theme parks. The venue is conveniently reached by all modes of transportation including local and regional trains (RER and Eurostar), shuttles from both Charles de Gaulle airport and Orly Airport, as well as a mere 35 minutes drive from Paris.
Contact
+33 160 457 500
Euro Disney Associes S.C.A.
Business Solutions
Boite Postale 112
F-77777 Marne-la-Vallee Cedex 4
As president of the French League Against Cancer, Dr Daniel Nizri highlights the organization’s 106-year legacy of fighting cancer through research funding, health promotion, patient support, and advocacy. He discusses…
After offloading its consumer healthcare division in 2022 and in view of the gradual erosion of its top seller, Somatuline, Ipsen opted to aggressively seek external assets to enrich its…
France is the third most significant clinical research destination in Europe, participating in 50 percent of the trials initiated across the continent. While favourable government policies and unique strengths such…
Hubert Mechin, president of AFCROs, the association that groups clinical research organisations in France, details the organisation’s efforts to help its members stay abreast of changes in the European regulatory…
With revenues projected to reach USD 27.01 billion in 2024, France’s pharma market is ranked fifth globally. Home to a number of well-established local pharma players and a sought-after destination…
Just five months after taking office, Aurélien Rousseau resigned from his role as health minister in protest against France’s recently adopted immigration law. Interim replacement Agnès Firmin Le Bodo, the…
France’s life sciences industry is falling behind its European neighbours, its growth deeply hampered, the French life sciences think tank G5 Santé claims, by abusive paybacks. While the government has…
The latest news from French healthcare and pharma, including an update on the hospital crisis; MaaT Pharma and Skyepharma’s new cGMP microbiome facility; Sanofi’s offloading of central nervous system drugs…
In the French government’s recent cabinet reshuffle, prime minister Elisabeth Borne’s former chief of staff, Aurélien Rousseau was appointed as the new minister of health. Rousseau, having piloted the Île-de-France…
The Contract Development and Manufacturing Organization (CDMO) sector has flousished in recent years as Big Pharma has shifted its attention to its core R&D activities and outsourced other supply chain…
Despite an uncertain macro-economic environment, the French health technology sector continues its growth trajectory, demonstrating both entrepreneurial dynamism and maturity, according to the new edition of the France Biotech study…
The latest news from French pharma, including fears of medicine shortages and suspension of online sales of paracetamol, CARMAT’s artificial heart product entering a study in France, Sanofi’s expanded deal…
See our Cookie Privacy Policy Here
